Benjamin F. Edwards & Company’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Benjamin F. Edwards & Company’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-12	Closed	-$1K	–	1940
2019 Q4	$1K	Buy	+12	New	+$1.35K	﹤0.01%	1847
2019 Q3	–	Sell	-200	Closed	-$34K	–	2018
2019 Q2	$34K	Hold	200	–	–	﹤0.01%	1020
2019 Q1	$34K	Hold	200	–	–	﹤0.01%	981
2018 Q4	$19K	Hold	200	–	–	﹤0.01%	1118
2018 Q3	$35K	Hold	200	–	–	﹤0.01%	958
2018 Q2	$28K	Buy	+200	New	+$28.4K	﹤0.01%	1005

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MGIM

M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Benjamin F. Edwards & Company's GWPH Position: Q1 2020 in Review

Benjamin F. Edwards & Company sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2020, closing a stake of 12 shares — an estimated $1K sold.

Benjamin F. Edwards & Company first reported a position in GWPH in Q2 2018 and held it in 6 quarters. The position peaked at $35K in Q3 2018. 289 funds tracked by Wall St. Rank hold GWPH as of Q1 2020.

Benjamin F. Edwards & Company reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2020 after selling out during the quarter.
Benjamin F. Edwards & Company sold 12 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2020, an estimated $1K.
Benjamin F. Edwards & Company first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2018 and held it in 6 quarters.
Benjamin F. Edwards & Company's GW Pharmaceuticals Plc American Depositary Shares position peaked at $35K in Q3 2018.
289 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2020.

Based on Benjamin F. Edwards & Company's 13F filing for Q1 2020, filed 7 May 2020.